Project Grant HT94252310680

Award Date 9/1/23
Completion Date 8/31/25
Dollars Obligated $248K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
The Department of Defense's Defense Health Agency awarded a $318,483 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used for a 2-year project to quantitatively measure acute and chronic lesion activity in a real-world, multi-site clinical MRI...
The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...
The Department of Defense's Defense Health Agency awarded a $319,240 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant, awarded on September 1, 2025, will fund research to characterize microRNAs involved in regulating human oligodendrocyte maturation and myelin formation. This research, to be conducted over 2 years until August 31, 2027, aims to transform healthcare for military service members, veterans, and the...
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
The federal Project Grant award of $465,568.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Johns Hopkins University on the role of epitranscriptomic modulators in response to bipolar androgen therapy. The award period runs from September 15, 2025 to September 14, 2027 and aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. As a leading...
The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
The Johns Hopkins University will receive $966,758 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered under Assistance Listing Number 12.420. Under this three-year award ending in August 2025, The Johns Hopkins University will investigate circulating central nervous system cell-derived extracellular vesicle based biomarkers to identify neurodegeneration and glial activation in...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $823,267 project grant to The Johns Hopkins University to conduct research on "Mitochondrial Heteroplasmy as a Novel Risk Factor for Myelodysplastic Syndromes". The research project will run from August 1, 2025 to July 31, 2028 and aims to investigate innovative approaches to address critical health challenges relevant to military personnel and the broader public. As a leading...

The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research. This grant will support Johns Hopkins' expertise in public health initiatives, biomedical science, and medical care to further the program's mission of transforming health care for Service Members and the American public.

Generated 4/9/24, 2:26 PM